During your consultation, our team will go over your health history and goals to help determine if a GLP-1 is right for you
At 72 weeks, all doses (6 mg, 12 mg, 36 mg) met the primary endpoint of superior body weight reduction versus placebo and achieved key secondary goals including 10%, 15%, and 20% weight loss and reduced waist circumference
For more information, visit ### Global clinical trial to test existing drugs as Long Covid treatments Western University and Schmidt Initiative for Long Covid will enroll more than 300 patients across four continents FOR IMMEDIATE RELEASE April 24, 2025 Contact: Swati Pandey, SILC [email protected] Contact: Cynthia Fazio, Western University [email protected] LONDON, ONTARIO, CANADA Spanning four continents and enrolling hundreds of people, a new clinical trial will test the effectiveness of two anti-inflammatory medicines as potential treatments for long COVID, scientists from Western University and the Schmidt Initiative for Long Covid (SILC) announced today
The formulation harnesses both pathways for metabolic and weight effects
Tracking multiple markers provides a more accurate view of real change